STOCK TITAN

IBEX Ltd: Robert Thomas Dechant proposes $250K sale

The notice also lists a prior 5,000-share sale on September 25, 2026, for gross proceeds of $225,095.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

IBEX Ltd officer and director Robert Thomas Dechant reported a proposed sale of 5,000 common shares, with an approximate sale date of November 9, 2026. The proposed sale has an aggregate market value of $250,031 and is pursuant to a Rule 10b5-1 plan established November 18, 2025. Dechant also reported a sale of 5,000 shares on September 25, 2026, for gross proceeds of $225,095. The shares covered by the proposed sale were acquired from the issuer through an RSA vest on December 28, 2018.

Proposed sale 5,000 common shares Approximate sale date November 9, 2026
Aggregate market value $250,031 Proposed sale
Prior sale 5,000 shares September 25, 2026
Gross proceeds $225,095 Prior sale on September 25, 2026
Shares acquired 5,000 shares RSA vest from the issuer on December 28, 2018
Rule 10b5-1 plan regulatory
"SOLD PURSUANT TO A RULE 10B5-1 PLAN"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IBEX shares is Robert Thomas Dechant proposing to sell?

Robert Thomas Dechant reported a proposed sale of 5,000 common shares, with an approximate sale date of November 9, 2026. The proposed sale has an aggregate market value of $250,031 and is pursuant to a Rule 10b5-1 plan established November 18, 2025.

How many IBEX shares did Robert Thomas Dechant sell in September 2026?

Robert Thomas Dechant reported selling 5,000 shares on September 25, 2026, for gross proceeds of $225,095.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading